Q2 Solutions’ Acquisition of Myriad RBM

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Myriad Genetics, Inc. on the deal.Myriad Genetics, Inc. (NASDAQ: MYGN), a genetic testing and precision medicine company, announced its…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here